Article Text

Download PDFPDF
CASE REPORT
Xp11 translocation renal cell carcinoma paraneoplastic syndrome presenting as cutaneous vasculitis: first reported case of yet another mask
  1. Claire Pascoe1,6,2,
  2. Daniel Christidis1,6,
  3. David Clouston3,
  4. Nathan Lawrentschuk1,2
  1. 1Department of Urology, Austin Health, Heidelberg, Victoria, Australia
  2. 2Cancer Surgery, Peter MacCallum Cancer Center, Melbourne, Victoria, Australia
  3. 3Department of Pathology, Tissue Path, Mount Waverley, Victoria, Australia
  4. 6YURO, Young Urology Researchers Organisation, Melbourne, VIC, Australia
  1. Correspondence to Dr Claire Pascoe, cea.pascoe{at}gmail.com

Summary

Renal cell carcinoma is historically known as the ‘great masquerader’ with 40% of patients experiencing a paraneoplastic syndrome. Translocation carcinoma represents one-third of renal cancer in paediatric patients but less than 3% of renal cancers in patients aged 18–45 years where the clinical course is often rapidly terminal. There are less than 10 reported cases of leucoclastic vasculitis associated with clear cell carcinoma reported in the literature and 10 case reports of translocation carcinoma in adults. To our knowledge, we present the first reported case of Xp11 translocation carcinoma presenting as cutaneous vasculitis, as part of a paraneoplastic syndrome, in an adult patient. Our case highlights that renal cell cancers are truly the ‘great masquerader’ and a rash can be the first sign of renal malignancy.

  • surgical oncology
  • urological surgery
  • urology
  • dermatology

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Contributors Conception and design: CP and NL. Manuscript writing + data collection: CP. Manuscript editing: DCh, DCl and NL.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Patient consent Obtained.

  • Provenance and peer review Not commissioned; externally peer reviewed.